Table 3. HAI titer of antisera against different viruses.
Antiserum groups |
Virus |
|||||
---|---|---|---|---|---|---|
H1 subtype |
H3 subtype |
B subtype |
||||
A/17/California/2009/38 | A/17/Perth/16/2009 | A/Wisconsin/67/2005 | A/Texas/JMM_30/2012 | B/56/Brisbane/60/80 | B/60/Massachusetts/20/2012 | |
Trivalent HA2-PP | 32–64N a | 32N | 64N | 64N | 16–32N | 32–64N |
H3-HA2-KLH | 32–64N | 16–32N | 32–64N | 64N | 16–32N | 16–32N |
Virus | 128* b | 128* | 128* | 128–256* | 256* | 256* |
Abbreviations: hemagglutination inhibition, HAI; keyhole limpet hemocyanin, KLH.
No significant difference in HAI activity was detected between antiserum and pre-immune serum.
Significant difference in HAI activity was detected between antiserum and pre-immune serum from mice given virus immunogens (*P<0.05).